# The Sixth Brainstorming Research Assembly for Young Neuroscientists (BraYn), Naples, Italy, 27–29 September 2023

**Authors:** Giovanni Ferrara

PMC · DOI: 10.3390/neurolint16010011 · Neurology International · 2024-01-19

## TL;DR

The BraYn conference supports young neuroscientists in Europe by fostering collaboration, offering educational opportunities, and providing a platform to present research and compete for grants.

## Contribution

The conference has grown significantly since 2018 and now serves as a flagship event for early-career neuroscience researchers in Europe.

## Key findings

- The 2023 BraYn conference in Naples attracted over 300 delegates.
- The conference promotes peer-to-peer discussions and interdisciplinary collaboration.
- Virtual editions were introduced during the pandemic to maintain engagement.

## Abstract

The BraYn association aims to bolster young neuroscientists’ research endeavors through collaborative support, fundraising assistance, and events promoting knowledge exchange and collaboration across Europe. Central to its mission is the annual BraYn conference, tailored for PhD students, postdocs, junior PIs, neurologists, and clinicians. This gathering champions cooperation, offering talks by key figures, educational workshops, and opportunities for attendees to present their work, compete for grants, and engage in international scientific experiences. The conference, established in 2018, has grown substantially in attendance and industry support and was adapted during the pandemic with virtual editions. The last sixth edition in Naples (27–29 September 2023) attracted over 300 delegates, focusing on peer-to-peer discussions, interdisciplinary collaboration, and interaction with renowned speakers, solidifying its place as a flagship event for Europe’s budding neuroscience researchers.

## Full-text entities

- **Diseases:** medulloblastoma (MESH:D008527), injuries (MESH:D014947), Neurodegeneration (MESH:D019636), COVID-19 (MESH:D000086382), Alzheimer's (MESH:D000544), NMOSD (MESH:D009471), nervous system disorders (MESH:D009422), injury to people or property (MESH:C000719191), nervous system damage (MESH:D020196), autoimmunity (MESH:D001327), tumor (MESH:D009369), nervous system tumors (MESH:D009423), Neuroinflammation (MESH:D000090862), inflammatory (MESH:D007249), Parkinson's (MESH:D010300), neurodevelopmental disorders (MESH:D002658), MS (MESH:D009103), neuronal death (MESH:D009410), Epilepsy (MESH:D004827), glioma (MESH:D005910), neurological diseases (MESH:D020271), psychiatric conditions (MESH:D001523), intracranial diseases (MESH:D020765), Oncology (MESH:D000072716)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10892396/full.md

---
Source: https://tomesphere.com/paper/PMC10892396